Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kathleen M. Burger"'
Autor:
Dileep R. Yavagal, Priyank Khandelwal, Manjot Grewal, Edward Greenberg, Sebastian Koch, Rami Algahtani, Amer M. Malik, Mohammad Rauf A Chaudhry, Robert M. Starke, David G. Daniel, Vasu Saini, Mithilesh Siddu, Muhammad Zeeshan Memon, Joshua Lukas, Taha Nisar, Christopher R. Leon Guerrero, Kathleen M. Burger, Shahram Majidi
Publikováno v:
Journal of Neuroimaging. 31:743-750
Background and purpose The first pass effect has been reported as a mechanical thrombectomy (MT) success metric in patients with large vessel occlusive stroke. We aimed to compare the clinical and neuroimagign outcomes of patients who had favorable r
Publikováno v:
Stroke. 52
Autor:
Adnan I Qureshi, Dimitri Sigounas, Christopher R. Leon Guerrero, Kathleen M. Burger, Shahram Majidi, Wayne J. Olan
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 27:2843-2848
The ASA/AHA guidelines recommend a fixed dose of 90 mg of intravenous (IV) recombinant tissue plasminogen activator (rt-PA) for acute stroke patients weighing more than 100 kg. We aimed to determine if body weight100 kg (and receiving0.9 mg/kg dose)
Autor:
Edward Greenberg, Wayne J. Olan, Christopher M. Putman, Dimitri Sigounas, Christopher R. Leon Guerrero, Kathleen M. Burger, Shahram Majidi, David G. Daniel, Muhammad Z Memon, Manjot Grewal
Publikováno v:
Stroke. 50
Background: First pass effect (FPE) is defined as achieving a TICI 3 recanalization with a single pass with no use of rescue therapy. We aimed to compare the clinical and radiological outcomes of patient who had FPE versus those who didn’t outside
Autor:
Kathleen M. Burger, Shahram Majidi, Dimitri Sigounas, Christopher R. Leon Guerrero, Shreya Gandhy
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 26:e126-e128
Central nervous system (CNS) involvement occurs in up to 50% of patients with systemic lupus erythematosus (SLE). Cerebral aneurysm formation is a rare complication of CNS lupus. The majority of these patients present with subarachnoid hemorrhage. We
Autor:
Shawn Sarin, Wayne J. Olan, Albert K. Chun, Shahram Majidi, Muhammad Z Memon, Kathleen M. Burger, Dimitri Sigounas, Christopher R. Leon Guerrero
Publikováno v:
Stroke. 49
Background: The AHA/ASA guideline recommends endovascular therapy for patients with acute ischemic stroke within 6 hours from symptom onset. Identification of the patients most likely to benefit (and those most likely to be harmed) from reperfusion p
Cocaine-Induced Acute Fatal Basilar Artery Thrombosis: Report of a Case and Review of the Literature
Publikováno v:
The American Journal of Case Reports
Patient: Male, 75 Final Diagnosis: Locked in syndrome Symptoms: — Medication: Aspririn Clinical Procedure: MRI brain Specialty: Neurology Objective: Rare disease Background: Cocaine use is a well-known contributing factor for both ischemic and hemo
Publikováno v:
Stroke. 48
Background: The ASA/AHA guidelines recommend a fixed dose of 90 mg of intravenous recombinant tissue plasminogen activator(rt-PA) for acute stroke patients weighing more than 100 kilograms(kg). Previous analyses in small studies have suggested that t
Autor:
Sudha Seshadri, Anita L. DeStefano, Timothy A. Thornton, Myriam Fornage, Charles Kooperberg, Wei-Min Chen, Kathleen M. Burger, Li Hsu, Bradford B. Worrall, Christopher S. Carlson, Kamakshi Lakshminarayan, Deborah A. Nickerson, Ulrike Peters, Gail P. Jarvik, John Hardy, Aaron R. Quinlan, Ani Manichaikul, Paul L. Auer, Rebecca D. Jackson, Mike A. Nalls, Stephen S. Rich, Daniel Seung Kim, W. T. Longstreth, Cara L. Carty, Leslie A. Lange, James F. Meschia, L. Adrienne Cupples, Andrew B. Singleton
Stroke is the second leading cause of death and the third leading cause of years of life lost. Genetic factors contribute to stroke prevalence, and candidate gene and genome-wide association studies (GWAS) have identified variants associated with isc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ef74a541392085b7085a3d5e0fed43
Publikováno v:
CNS Spectrums. 10:539-549
Stroke is a common cause of death and disability throughout the world. Acute neurologic deficits due to ischemic injury deserve rapid recognition and diagnosis in order to provide effective therapy. Intravenous tissue plasminogen activator (t-PA) pro